| 000 | 01794 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517172145.0 | ||
| 264 | 0 | _c20180510 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1177-8881 | ||
| 024 | 7 |
_a10.2147/DDDT.S141007 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNosek, Krzysztof | |
| 245 | 0 | 0 |
_aA comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients. _h[electronic resource] |
| 260 |
_bDrug design, development and therapy _c2017 |
||
| 300 |
_a2409-2419 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Cutaneous |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
| 650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
| 650 | 0 | 4 |
_aCancer Pain _xdrug therapy |
| 650 | 0 | 4 |
_aConstipation _xchemically induced |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aFentanyl _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactulose _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMorphine _xadministration & dosage |
| 650 | 0 | 4 |
_aOxycodone _xadministration & dosage |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aLeppert, Wojciech | |
| 700 | 1 | _aNosek, Hanna | |
| 700 | 1 | _aWordliczek, Jerzy | |
| 700 | 1 | _aOnichimowski, Dariusz | |
| 773 | 0 |
_tDrug design, development and therapy _gvol. 11 _gp. 2409-2419 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/DDDT.S141007 _zAvailable from publisher's website |
| 999 |
_c27517024 _d27517024 |
||